Enzyme India Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 1.00 M
as on 17-07-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.07 Cr
as on 17-07-2024
- Satisfied Charges ₹ 4.20 Cr
as on 17-07-2024
- Revenue 26.11%
(FY 2023)
- Profit -42.12%
(FY 2023)
- Ebitda -54.42%
(FY 2023)
- Net Worth 357.71%
(FY 2023)
- Total Assets 17.71%
(FY 2023)
About Enzyme India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹4.07 Cr. The company has closed loans amounting to ₹4.20 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vishal Mehta, Neena Mehta, and Naveen Jaidka serve as directors at the Company.
- CIN/LLPIN
U24294TN1995PTC029871
- Company No.
029871
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jan 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Enzyme India Private Limited offer?
Enzyme India Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Additive, Textile, Dyeing & Finishing Chemical, Textile Chemical, Food Enzymes, Artificial Sweetener, Nutraceuticals & Dietary Supplements, Protein Powder, Bird Food, Poultry & Animal Food, Animal Feed Enzymes.
Who are the key members and board of directors at Enzyme India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Mehta  | Director | 30-Sep-2008 | Current |
| Neena Mehta | Director | 08-May-2023 | Current |
| Naveen Jaidka | Whole-Time Director | 18-Jan-1995 | Current |
Financial Performance of Enzyme India.
Enzyme India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 26.11% increase. The company also saw a substantial fall in profitability, with a 42.12% decrease in profit. The company's net worth Soared by an impressive increase of 357.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enzyme India?
In 2023, Enzyme India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Apr 2022 | ₹0.71 M | Open |
Others Creation Date: 19 Nov 2021 | ₹4.00 Cr | Open |
Others Creation Date: 09 Jan 2017 | ₹2.73 Cr | Satisfied |
How Many Employees Work at Enzyme India?
Unlock and access historical data on people associated with Enzyme India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enzyme India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enzyme India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
